The significance of titin antibodies in myasthenia gravis: Correlation with thymoma and severity of myasthenia gravis

Journal of Neurology

Volumn 251, Issue 8, 2004, Pages 1006-1011

  Chen, Xiang Jun ^a   Qiao, Jian ^a   Xiao, Bao Guo ^a,b   Lu, Chuan Zhen ^a  

^a FUDAN UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acetylcholine receptor antibodies; Myasthenia gravis; Thymoma; Titin antibodies

Indexed keywords

AUTOANTIBODY; COMPLEMENTARY DNA; CONNECTIN; TITIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SCREENING; ARTICLE; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA PURIFICATION; DNA SEQUENCE; DNA TRANSFECTION; EPITHELIUM TUMOR; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMECTOMY; THYMOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIBODIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYASTHENIA GRAVIS; PROTEIN KINASES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TIME FACTORS;

EID: 4344608976     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aarli JA, Skeie GO, Mygland A, Gilhus NE (1998) Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance. Ann NY Acad Sci 841:505-515
2. Aarli JA, Flood PR, Gilhus NE, Hofstad H, Matre R (1988) Non-receptor striated muscle antibodies in sera from patients with myasthenia gravis. Monogr Allergy 25:128-134
3. Aarli JA (2001) Titin, thymoma, and myasthenia gravis. Arch Neurol 58:869-870
4. Baggi F, Andreeta F, Antozzi C, Simoncini O, Confalonieri P, Labeit S, Cornelio F, Mantegazza R (1998) Antititin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma. Ann NY Acad Sci 841:538-541
5. Buckley C, Newson-Davis J, Willcox N, Vincent A (2001) Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? Neurology 57:1579-1582
6. Gautel M, Lakey A, Barlow DP, Holmes Z, Scales S, Leonard K, Labeit S, Mygland A, Gilhus NE, Aarli JA (1993) Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 43:1581-1585
7. Labeit S, Kolmerer B (1995) Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 270:293-296
8. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD (1976) Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26:1054-1059
9. Marx A, Wilisch A, Schultz A, Greiner A, Magi B, Pallini V, Schalke B, Toyka K, Nix W, Kirchner T, Muller-Hermelink HK (1996) Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis. Am J Pathol 148:1839-1850
10. Romi F, Skeie GO, Aarli JA, Gilhus NE (2000a) The severity of myasthenia gravis correlates with the serum concentration of titin and ryabodine receptor antibodies. Arch Neurol 57:1596-1600
11. Romi F, Skeie GO, Aarli JA, Gilhus NE (2000b) Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol 247:369-375
12. Romi F, Bo L, Skeie GO, Myking A, Aarli JA, Gilhus NE (2002) Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 128:82-89
13. Skeie GO, Pandey JP, Aarli JA, Gilhus NE (1997) Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity 26:111-116
14. Somnier FE, Engel PJH (2002) The occurrence of anti-titin antibodies and thymomas. A population survey of MG 1970-1999. Neurology 59:92-98
15. Toyka KV, Brachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397-399
16. Voltz RD, Albrich WC, Nagele A, Schumm F, Wick M, Freiburg A, Gautel M, Thaler HT, Aarli J, Kirchner T, Hohlfeld R (1997) Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 49:1454-1457
17. Voltz R, Albrich W, Hohlfeld R, Nagel D, Wick M, Kirchner T, Sommer N, Illa I, Kaminski H, Schumm F (2003) Antititin antibodies are not associated with a specific thymoma histology. J Neurol Neurosurg Psychiatry 74:282
18. Willcox N (1993) Myasthenia gravis. Curr Opin Immunol 5:910-917
19. Williams CL, Hay JE, Huiatt TW, Lennon VA (1992) Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab Invest 66: 331-336
20. Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter JM, Gomez L, Bourquin C, Bach JF, Garchom HJ (2001) Anti-titin antibodies in myasthenia gravis. Arch Neurol 58: 885-890